» Articles » PMID: 33536259

Minute Ventilation/carbon Dioxide Production in Chronic Heart Failure

Abstract

In chronic heart failure, minute ventilation (') for a given carbon dioxide production (' ) might be abnormally high during exercise due to increased dead space ventilation, lung stiffness, chemo- and metaboreflex sensitivity, early metabolic acidosis and abnormal pulmonary haemodynamics. The ' ' relationship, analysed either as ratio or as slope, enables us to evaluate the causes and entity of the '/perfusion mismatch. Moreover, the ' axis intercept, when ' is extrapolated to 0, embeds information on exercise-induced dead space changes, while the analysis of end-tidal and arterial CO pressures provides knowledge about reflex activities. The ' ' relationship has a relevant prognostic power either alone or, better, when included within prognostic scores. The ' ' slope is reported as an absolute number with a recognised cut-off prognostic value of 35, except for specific diseases such as hypertrophic cardiomyopathy and idiopathic cardiomyopathy, where a lower cut-off has been suggested. However, nowadays, it is more appropriate to report ' ' slope as percentage of the predicted value, due to age and gender interferences. Relevant attention is needed in ' ' analysis in the presence of heart failure comorbidities. Finally, ' ' abnormalities are relevant targets for treatment in heart failure.

Citing Articles

It's Time to Run!.

Cattadori G, Picozzi A, Di Marco S J Clin Med. 2023; 12(17).

PMID: 37685825 PMC: 10488612. DOI: 10.3390/jcm12175758.


Identification of Non-Invasive Exercise Thresholds: Methods, Strategies, and an Online App.

Keir D, Iannetta D, Maturana F, Kowalchuk J, Murias J Sports Med. 2021; 52(2):237-255.

PMID: 34694596 DOI: 10.1007/s40279-021-01581-z.

References
1.
Guazzi M, Marenzi G, Alimento M, Contini M, Agostoni P . Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation. 1997; 95(7):1930-6. DOI: 10.1161/01.cir.95.7.1930. View

2.
Agostoni P, Magini A, Andreini D, Contini M, Apostolo A, Bussotti M . Spironolactone improves lung diffusion in chronic heart failure. Eur Heart J. 2004; 26(2):159-64. DOI: 10.1093/eurheartj/ehi023. View

3.
Guazzi M, Palermo P, Pontone G, Susini F, Agostoni P . Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure. Am J Cardiol. 1999; 84(9):1038-43. DOI: 10.1016/s0002-9149(99)00495-6. View

4.
Arena R, Owens D, Arevalo J, Smith K, Mohiddin S, McAreavey D . Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy. Med Sci Sports Exerc. 2008; 40(5):799-805. DOI: 10.1249/MSS.0b013e31816459a1. View

5.
Kato T, Stevens G, Jiang J, Schulze P, Gukasyan N, Lippel M . Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation. J Heart Lung Transplant. 2013; 32(3):333-40. PMC: 4119928. DOI: 10.1016/j.healun.2012.11.026. View